1887

Abstract

SUMMARY

A series of herpes simplex virus isolates were recovered from a bone marrow transplant patient who received prolonged acyclovir therapy for indolent herpes simplex mouth and throat ulceration. Of 14 isolates received 10 were resistant to acyclovir and partially resistant to phosphonoacetic acid. Biochemical characterization revealed that resistance was due to an alteration in the virus DNA polymerase. DNA sequence analysis of the polymerase gene of a plaque-purified resistant virus isolate revealed a single nucleotide change when compared with the sequence of the gene of a plaque-purified sensitive isolate. This single base change resulted in a predicted amino acid substitution of Gly to Ser at residue number 841, a putative functional region of the polymerase.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-70-2-375
1989-02-01
2021-10-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/70/2/JV0700020375.html?itemId=/content/journal/jgv/10.1099/0022-1317-70-2-375&mimeType=html&fmt=ahah

References

  1. Barry D. W., Nusinoff-Lehrman S., Ellis N. M., Biron K. K., Furman P. A. 1985; Viral resistance: clinical experience. Scandinavian Journal of Infectious Diseases supplement 47:155–164
    [Google Scholar]
  2. Biggin M. D., Gibson T. J., Hong G. F. 1983; Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination. Proceedings of the National Academy of SciencesU.S.A 80:3963–3965
    [Google Scholar]
  3. Coen D. M., Schaffer P. A. 1980; Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1. Proceedings of the National Academy of SciencesU.S.A 77:2265–2269
    [Google Scholar]
  4. Collins P. 1988; Viral sensitivity following the introduction of acyclovir. American Journal of Medicine 85:129–134
    [Google Scholar]
  5. Collins P., Oliver N. M. 1986; Sensitivity monitoring of herpes simplex virus isolates from patients receiving acyclovir. Journal of Antimicrobial Chemotherapy 18: supplement B 103–112
    [Google Scholar]
  6. Collins P., Appleyard G. A., Oliver N. M. 1982; Sensitivity of herpes virus isolates from acyclovir clinical trials. American Journal of Medicine 73:380–382
    [Google Scholar]
  7. Cruikshank R., Duguid J. P., Marmion B. P., Swain R. H. A. 1975; Medical Microbiology. II The Practice of Medical Microbiology, 12. Edinburgh: Churchill Livingstone;
    [Google Scholar]
  8. Field H. J., Darby G., Wildy P. 1980; Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus. Journal of General Virology 49:115–124
    [Google Scholar]
  9. Furman P.A., Coen D. M., St Clair M. H., Schaffer P. A. 1981; Acyclovir-resistant mutants of herpes simplex virus type 1 express altered DNA polymerase or reduced acyclovir phosphorylating activities. Journal of Virology 40:936–941
    [Google Scholar]
  10. Gibbs J. S., Chiou H. C., Hall I. D., Mount D. W., Retondo M. J., Weller S. K., Coen D. M. 1985; Sequence and mapping analyses of herpes simplex virus DNA polymerase gene predict a C-terminal substrate binding domain. Proceedings of the National Academy of SciencesU.S.A 82:7969–7973
    [Google Scholar]
  11. Hill T. J., Field H. J., Blyth W. A. 1975; Acute and recurrent infection with herpes simplex virus in the mouse : a model for studying latency and recurrent disease. Journal of General Virology 28:341–353
    [Google Scholar]
  12. Klemperer H. G., Haynes G. R., Shedden W. I. H., Watson D. H. 1967; A virus-specific thymidine kinase in BHK cells infected with herpes simplex virus. Virology 31:120–128
    [Google Scholar]
  13. Knopf C. W. 1987; The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved. Journal of General Virology 68:1429–1443
    [Google Scholar]
  14. Larder B. A., Darby G. 1985; Selection and characterization of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities. Virology 146:262–271
    [Google Scholar]
  15. Larder B. A., Darby G. 1986; Susceptibility to other antiherpes drugs of pathogenic variants of herpes simplex virus selected for resistance to acyclovir. Antimicrobial Agents and Chemotherapy 29:894–898
    [Google Scholar]
  16. Larder B. A., Derse D., Cheng Y-C., Darby G. 1983; Properties of purified enzymes induced by pathogenic drug-resistant mutants of herpes simplex virus: evidence for virus variants expressing normal DNA polymerase and altered thymidine kinase. Journal of Biological Chemistry 258:2027–2033
    [Google Scholar]
  17. Larder B. A., Kemp S. D., Darby G. 1987; Related functional domains in virus DNA polymerases. EMBO Journal 6:169–175
    [Google Scholar]
  18. Meyers J. D., Wade J. C., Mitchell C. D., Saral R., Leitman P. S., Durak D. T., Levin M. J., Segreti A. C., Balfour H. H. jr 1982; Multicentre collaborative trial of intravenous acyclovir for the treatment of mucocutaneous herpes simplex infection in the immunocompromised host. American Journal of Medicine 73:229–235
    [Google Scholar]
  19. Mitchell C. D., Gentry S. R., Boen J. R., Bean B., Groth K. E., Balfour H. H. JR 1981; Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet i:1389–1392
    [Google Scholar]
  20. Parker A. C., Craig J. I. O., Collins P., Oliver N. M., Smith I. 1987; Acyclovir resistant herpes simplex virus infection due to altered DNA polymerase. Lancet ii:1461
    [Google Scholar]
  21. Peutherer J. F., Smith I. W., Robertson D. H. H. 1982; Genital infections with herpes simplex virus type 1. Journal of Infection 4:33–35
    [Google Scholar]
  22. Pignatti P. F., Cassai E., Meneguzzi G., Chenciner N., Milanesi G. 1979; Herpes simplex virus DNA isolation from infected cells with a novel procedure. Virology 93:260–264
    [Google Scholar]
  23. Quinn J. P., McGeoch D. J. 1985; DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Research 13:8143–8163
    [Google Scholar]
  24. Sanger F., Nicklen S., Coulson A. R. 1977; DNA sequencing with chain-terminating inhibitors. Proceedings of the National Academy of SciencesU.S.A 74:5463–5467
    [Google Scholar]
  25. Schnipper L. E., Crumpacker C. S. 1980; Resistance of herpes simplex virus to acycloguanosine : the role of viral thymidine kinase and DNA polymerase. Proceedings of the National Academy of SciencesU.S.A 77:2270–2273
    [Google Scholar]
  26. Shepp D. H., Newton B. A., Dandliker P. S., Flournoy N., Meyers J. D. 1985; Oral acyclovir therapy of mucocutaneous herpes simplex virus infection in immunocompromised patients. Annals of Internal Medicine 102:783–785
    [Google Scholar]
  27. Smith K. O., Kennell W. L., Poirier R. H., Lynd F. T. 1980; In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine). Antimicrobial Agents and Chemotherapy 17:144–150
    [Google Scholar]
  28. Wade J. C., Newton B., Mclaren C., Flournoy N., Keeney R. E., Meyers J. D. 1982; Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. Annals of Internal Medicine 96:265–269
    [Google Scholar]
  29. Whitley R. J., Levin M., Barton N., Hershey B. J., Davis G., Keeney R. E., Whelchel J., Diethelm A. G., Kartus P., Soony S.-J. 1984; Infections caused by herpes simplex virus in the immunocompromised host : natural history and topical acyclovir therapy. Journal of Infectious Diseases 150:323–329
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-70-2-375
Loading
/content/journal/jgv/10.1099/0022-1317-70-2-375
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error